A randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy, safety and tolerability of ezetimibe 10 mg or placebo added to existing atorvastatin 10 mg or 20 mg in attaining low-density lipoprotein cholesterol target levels in patients with hypercholesterolemia and coronary heart disease.
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Atorvastatin; Ezetimibe
- Indications Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- 19 Oct 2006 Status change
- 22 Oct 2005 New trial record.